SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
51 hedge funds and large institutions have $129M invested in scPharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+18
Holders Change %
+54.55%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
20
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$10.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.5M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
+$4.25M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.91M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.86M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $1.48K | +$1.21K | +165 | +458% |
|
52
Millennium Management
New York
| – | -$259K | -35,059 | Closed |
|
53
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$87K | -11,759 | Closed |
|
54
Victory Capital Management
San Antonio,
Texas
| – | -$40K | -5,420 | Closed |
|
|
MAM
55
Meeder Asset Management
Dublin,
Ohio
| – | -$6K | -729 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -117 | Closed |
|